SB953 establishes a new “Hospital Price Transparency Act” within Hawaii law. The bill ties hospital debt collection rights to compliance with federal hospital price transparency requirements: if a hospital is not in material compliance with the federal transparency laws and rules when services are provided, it may not pursue collection actions for the related debt. It also allows patients or patient guarantors to sue to determine whether a hospital was materially out of compliance, and it pauses collection activity while that lawsuit is pending.
If a court finds a hospital materially out of compliance, the bill requires the hospital to refund amounts already paid on the debt, pay a penalty equal to the debt amount, dismiss related court actions with prejudice, pay the patient’s attorney’s fees and costs, remove related credit reporting, and notify the Department of Health. The bill also requires hospitals to publicly post Medicare reimbursement rates by October 1, 2025, and directs the Department of Health to assess hospital adherence to federal transparency rules, provide technical assistance, and publish a public list of hospitals that perform poorly beginning February 1, 2026. Violations of the posting requirement are treated as unfair and deceptive acts or practices under Hawaii consumer protection law.
The bill’s impact on state law is to create a new enforcement framework in Chapter 323 that combines hospital price transparency, consumer protection, and debt collection restrictions. It gives the Department of Health oversight and rulemaking authority, adds public disclosure obligations, and creates private enforcement through patient lawsuits. It also affects hospitals, patient guarantors, debt collectors, and consumer reporting agencies by limiting collection and credit-reporting actions tied to noncompliant hospital billing practices.
The general sentiment reflected in the bill text is strongly pro-consumer and pro-transparency, with an emphasis on accountability for hospitals that do not comply with federal pricing rules. Because there are no committee transcripts or recorded votes provided, there is no additional evidence of support or opposition from legislative debate. The structure of the bill suggests a policy goal of pressuring hospitals to comply with transparency requirements by linking noncompliance to financial and reputational consequences.
The main point of contention likely centers on enforcement and administrative burden. Hospitals may object to the bill’s restrictions on collections, the possibility of lawsuits, mandatory refunds and penalties, public posting of Medicare reimbursement rates, and the public list of poorly performing hospitals. Supporters would likely emphasize patient protections, clearer pricing, and stronger compliance with federal transparency standards. The bill also raises questions about how “material compliance” will be determined and how the Department of Health will implement and monitor the new requirements.
SB953 would add a new part to Chapter 323, Hawaii Revised Statutes, creating state-level hospital price transparency enforcement tied to federal requirements under section 2718(e) of the Public Health Service Act and related CMS rules. It would prohibit certain debt collection actions by hospitals that are not materially compliant with transparency laws, authorize patient lawsuits, impose refund and penalty remedies, require public posting of Medicare reimbursement rates, and direct the Department of Health to conduct annual performance assessments and publish noncompliant hospitals. It also makes violations of the posting requirement an unfair and deceptive act or practice under section 480-2 and authorizes DOH rulemaking to implement the new law.
No committee transcripts or vote history were provided, so there is no recorded debate to gauge formal support or opposition. Based on the bill text and report description, the measure appears to be framed as a consumer-protection and transparency bill, suggesting a generally favorable posture toward patients and public disclosure. The absence of recorded votes or testimony means any broader legislative sentiment cannot be confirmed from the supplied materials.
The likely areas of contention are the bill’s enforcement mechanisms and their effect on hospital billing operations. Hospitals may view the collection ban, lawsuit stay, refund and penalty provisions, attorney’s fee shifting, and public disclosure of poor performance as punitive and administratively burdensome. Patients and consumer advocates would likely support these provisions as necessary to ensure compliance with federal price transparency rules and to protect patients from aggressive collection practices tied to opaque billing. Another possible dispute is the standard for “material compliance,” which the bill leaves to judicial determination using CMS guidance, potentially creating uncertainty for hospitals and litigants.